CORONA Remedies has secured Eurasian Economic Union - Good Manufacturing Practices (EAEU-GMP) Certification for its finished dosage facility situated at Bhayla, Gujarat. This certification paves the way for the company’s entry into five EAEU member nations -- Russia, Kyrgyzstan, Armenia, Belarus, and Kazakhstan -- under a B2B business model.
It unlocks access to a pharmaceutical market estimated at $25 billion and aligns seamlessly with the company’s long-term vision of fostering sustainable international partnerships. EAEU-GMP certification further strengthens the company’s focus across its four key therapeutic pillars -- Women’s Health, Cardio-Diabetes, Pain Management, and Urology.
CORONA Remedies is primarily engaged in the business of manufacturing, trading and marketing of pharmaceutical products.
